This dual negative correlation, combined with the characteristic reduction in immune cell infiltration, collectively suggests that in breast cancer patients with high TRNT1 expression, their tumour microenvironment may present a state of insufficient immune effector cell recruitment and immune regulatory factor imbalance. The gene discussed is TRNT1; the disease is breast carcinoma.